Meihua International (MHUA) chair Wang Ailiang named as insider in Form 3

Rhea-AI Filing Summary

Meihua International Medical Technologies Co., Ltd. filed an initial Form 3 for officer Wang Ailiang, who is listed as Chairwoman. The filing reports no insider transactions, no current share holdings, and no outstanding derivative positions for her at this time.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Ailiang

(Last) (First) (Middle)

NO. 2 VILLAGER GROUP

QINGSHUIWAN VILLAGE, SHIYANG, XINTIAN

(Street)

YONGZHOU HUNAN PROVINCE 425704

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Meihua International Medical Technologies Co., Ltd. [ MHUAF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairwoman

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Ailiang Wang	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Meihua (MHUA) Form 3 filed for Wang Ailiang show?

The Form 3 shows that Wang Ailiang, listed as Chairwoman of Meihua International Medical Technologies, is now a reporting person. The filing reports no transactions, no share holdings, and no derivative positions for her.

Does the Meihua (MHUA) Form 3 report any insider trades by Wang Ailiang?

No, the Form 3 reports no insider transactions by Wang Ailiang. The transaction section is empty, indicating no reported purchases, sales, exercises, gifts, or other movements of Meihua securities in this filing.

Are any Meihua (MHUA) shares or options listed as held by Wang Ailiang?

The Form 3 lists no share holdings and shows no derivative positions for Wang Ailiang. Holding entries are zero and the derivative summary is empty, so no common stock or options are reported as owned in this filing.

What insider role does Wang Ailiang have at Meihua (MHUA)?

Wang Ailiang is identified as an officer of Meihua International Medical Technologies with the title Chairwoman. She is not flagged as a director or a ten percent owner in the Form 3 reporting-person details.

Does the Meihua (MHUA) Form 3 mention any Rule 10b5-1 trading plan?

No, the structured Form 3 data and footnotes do not reference any Rule 10b5-1 trading plan. The filing contains no noted pre-planned trading arrangements or related disclosures for Wang Ailiang.